Moderna Named a Top Employer by Science for Twelfth Consecutive Year ACCESSWIRE
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on MRNA
    Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
    7:00a ET October 13 '26 ACCESSWIRE

    CAMBRIDGE, MA / ACCESS Newswire / October 13, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, November 6, 2026 to report its third quarter 2026 financial results, and provide a corporate update.

    A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.

    Webcast: https://investors.modernatx.com

    The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

    About Moderna

    Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

    With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

    Investors:Lavina TalukdarSenior Vice President & Head of Investor Relations617-209-5834Lavina.Talukdar@modernatx.com

    SOURCE: Moderna, Inc.

    View the original press release on ACCESS Newswire

    COMTEX_494166034/2457/2026-10-13T07:00:11

    AI-Designed Biologics Are Moving From the Screen to the Bench, and De...
    9:45a ET October 14 '26 GlobeNewswire
    Moderna to Report Third Quarter 2026 Financial Results on Friday, Nov...
    7:00a ET October 13 '26 ACCESSWIRE
    2026 Takes a Promising Turn in the Fight Against Cancer as Five Advan...
    9:59a ET October 7 '26 GlobeNewswire
    Moderna, Inc. to Join the Nasdaq-100 Index(R) Beginning October 9, 20...
    8:56a ET October 2 '26 GlobeNewswire
    Moderna Adds Chief Operating Officer Role as Company Expands into Onc...
    7:00a ET September 30 '26 ACCESSWIRE
    Moderna Announces Late-Breaking Data to be Presented at ESMO Congress...
    10:12a ET September 21 '26 ACCESSWIRE
    A $57 Billion Antiviral Market Is Taking Shape As The World Prepares ...
    9:00a ET September 15 '26 GlobeNewswire
    AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
    10:01a ET September 14 '26 CNW Group
    Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convert...
    7:00a ET August 28 '26 ACCESSWIRE
    Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vac...
    3:57p ET August 27 '26 ACCESSWIRE

    Market data provided by News provided by